David Hardy, M.D.
David Hardy, M.D., is director of infectious diseases at Cedars-Sinai Medical Center in Los Angeles and an associate professor of medicine-in-residence at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). He gained his medical degree from the Baylor College of Medicine in Houston, Texas, in 1981, completed a residency in internal medicine at Harbor-UCLA Medical Center in Torrance, California in 1984 and a clinical fellowship in infectious diseases and immunology in 1986 at UCLA School of Medicine. Later in his career he also completed a postdoctoral fellowship in basic retrovirology in 2002, also at the UCLA School of Medicine. A diplomat of the American Board of Internal Medicine, Dr. Hardy is a member of numerous professional societies including the American Academy of HIV Medicine, for whom he serves as a member of the National Board of Directors and Chairman of the California/Hawaii Chapter. He works with several community organizations, and since 1988 he has been president of the Los Angeles Physicians AIDS Forum, which he co-founded. He has served on the scientific committees for various national and international HIV congresses. Dr. Hardy has been principal investigator on a number of HIV clinical trials. Disclosures Dr. Hardy has received grants or research support from Boehringer Ingelheim, Gilead Sciences, GlaxoSmithKline, Pfizer, and Tibotec. He has served as a consultant for Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Monogram, Pfizer, and Tibotec. He has received fees for non-CME services from Gilead Sciences, Pfizer, and Tibotec. He owns stock in Merck.
Latest by David Hardy, M.D.
Full Audio and Slides:Listen to Audio (77 min.)Download AudioDownload SlidesListen to Audio With SlidesWritten Summaries,Audio and SlidesDivided by Topic:Research UpdateListen to Audio (45 min.)Read Written SummaryDownload AudioDownload SlidesCase St...